BlackRock Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$181M Buy
1,973,675
+603,922
+44% +$52.1M 0.09% 272
2016
Q3
$116M Buy
1,369,753
+118,265
+9% +$9.93M 0.06% 372
2016
Q2
$102M Buy
1,251,488
+56,294
+5% +$4.29M 0.05% 386
2016
Q1
$85.4M Sell
1,195,194
-198,071
-14% -$13.3M 0.05% 428
2015
Q4
$99.1M Sell
1,393,265
-17,326
-1% -$1.16M 0.05% 381
2015
Q3
$86.7M Sell
1,410,591
-123,121
-8% -$8.61M 0.05% 403
2015
Q2
$111M Sell
1,533,712
-124,443
-8% -$9.19M 0.06% 360
2015
Q1
$127M Buy
1,658,155
+17,059
+1% +$1.22M 0.07% 327
2014
Q4
$110M Buy
1,641,096
+106,069
+7% +$6.69M 0.06% 366
2014
Q3
$93.1M Buy
1,535,027
+17,558
+1% +$1.08M 0.05% 401
2014
Q2
$89.1M Buy
1,517,469
+230,320
+18% +$13.5M 0.05% 409
2014
Q1
$74.6M Buy
1,287,149
+31,001
+2% +$1.66M 0.05% 436
2013
Q4
$67.3M Buy
1,256,148
+66,965
+6% +$3.97M 0.04% 446
2013
Q3
$73.5M Buy
1,189,183
+148,437
+14% +$8.88M 0.05% 426
2013
Q2
$63.1M Buy
+1,040,746
New +$62M 0.05% 431

Other funds holding DGX

BlackRock Group's DGX Position: Q4 2016 in Review

BlackRock Group increased its Quest Diagnostics (DGX) stake by 44% in Q4 2016, buying an estimated $52.1M and bringing the position to 1,973,675 shares worth $181M. The position accounts for 0.09% of the portfolio, ranked #272.

BlackRock Group first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • BlackRock Group held 1,973,675 shares of Quest Diagnostics worth $181M as of Q4 2016.
  • BlackRock Group bought 603,922 Quest Diagnostics shares in Q4 2016, an estimated $52.1M.
  • Quest Diagnostics made up 0.09% of BlackRock Group's portfolio in Q4 2016, its #272 holding.
  • BlackRock Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.